Variant report
Variant | esv3450746 |
---|---|
Chromosome Location | chr8:85532265-85538309 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:85533470..85536280-chr8:85567297..85568905,2 | K562 | blood: | |
2 | chr8:85538196..85539101-chr8:85944207..85944819,2 | MCF-7 | breast: | |
3 | chr8:85534205..85536062-chr8:85543701..85545825,2 | MCF-7 | breast: | |
4 | chr8:85538123..85539046-chr8:85966580..85967573,4 | MCF-7 | breast: | |
5 | chr8:85532892..85534737-chr8:85962083..85963895,2 | K562 | blood: | |
6 | chr8:85538135..85538922-chr8:86202235..86203001,3 | MCF-7 | breast: | |
7 | chr8:85538159..85539035-chr8:85943804..85944923,5 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544061850 | chr8:85533203-85533204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560764841 | chr8:85533204-85533205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527253674 | chr8:85533284-85533285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372386392 | chr8:85533285-85533286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529821974 | chr8:85533313-85533314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145224304 | chr8:85533376-85533377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183964482 | chr8:85533391-85533392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571618848 | chr8:85533396-85533397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186806024 | chr8:85533403-85533404 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371033025 | chr8:85533417-85533418 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547255483 | chr8:85533426-85533427 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28695582 | chr8:85533458-85533459 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs536400582 | chr8:85533459-85533460 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554457607 | chr8:85533488-85533489 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78191906 | chr8:85533492-85533493 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192384822 | chr8:85533515-85533516 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567793631 | chr8:85533522-85533523 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185748225 | chr8:85533523-85533524 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538681682 | chr8:85533530-85533531 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558138417 | chr8:85533549-85533550 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574860297 | chr8:85533552-85533553 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544123273 | chr8:85533555-85533556 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143312082 | chr8:85533556-85533557 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574608160 | chr8:85533559-85533560 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112775786 | chr8:85533572-85533573 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141565979 | chr8:85533573-85533574 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs28446816 | chr8:85533583-85533584 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs545474679 | chr8:85533602-85533603 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368635941 | chr8:85533604-85533605 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565293719 | chr8:85533606-85533607 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530896375 | chr8:85533653-85533654 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189875403 | chr8:85533658-85533659 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567855480 | chr8:85533659-85533660 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530368072 | chr8:85533664-85533665 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546883959 | chr8:85533677-85533678 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567013439 | chr8:85533686-85533687 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538363522 | chr8:85533687-85533688 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552965664 | chr8:85533693-85533694 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370853365 | chr8:85533720-85533721 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568374899 | chr8:85533721-85533722 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537430145 | chr8:85533747-85533748 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112175251 | chr8:85533751-85533752 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574641291 | chr8:85533790-85533791 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs386727366 | chr8:85533793-85533794 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553691407 | chr8:85533795-85533796 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182086375 | chr8:85533798-85533799 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143580851 | chr8:85533799-85533800 | Active TSS Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545736132 | chr8:85533804-85533805 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147494356 | chr8:85533820-85533821 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565365148 | chr8:85533821-85533822 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:85533200-85533400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:85533400-85533600 | Enhancers | Pancreas | Pancrea |
3 | chr8:85533400-85533800 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
4 | chr8:85533400-85533800 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr8:85533400-85533800 | Active TSS | H9 Cell Line | embryonic stem cell |
6 | chr8:85533400-85533800 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
7 | chr8:85533400-85533800 | Active TSS | HUES64 Cell Line | embryonic stem cell |
8 | chr8:85533400-85533800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
9 | chr8:85533400-85533800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr8:85533400-85533800 | Flanking Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr8:85533400-85534000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
12 | chr8:85536800-85537200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr8:85537200-85537600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr8:85537600-85538200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr8:85537600-85538400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
16 | chr8:85537800-85538600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr8:85538000-85538200 | Enhancers | Primary hematopoietic stem cells | blood |
18 | chr8:85538000-85538800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |